Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04824092 |
|---|---|
| Brief Title: | Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients (frontMIND) |
| First Submitted : | March 22, 2021 |
| First Submitted that Met QC Criteria : | March 26, 2021 |
| First Posted : | April 1, 2021 |
| Last Update Submitted that Met QC Criteria : | April 4, 2023 |
| Last Update Posted : | April 6, 2023 |